Jul 27, 2015 8:00 am EDT VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs
Jun 23, 2015 8:00 am EDT VolitionRx Partners with Two Market Access Consulting Agencies to Support Market Access of NuQ(R) Colorectal Cancer Tests in Europe
May 12, 2015 7:50 am EDT VolitionRx Announces First Quarter 2015 Financial Results and Business Update
May 8, 2015 8:00 am EDT VolitionRx Accelerates Clinical Trial with University Hospital Bonn, Germany Evaluating NuQ® Assays in Most Prevalent Cancers
May 6, 2015 8:00 am EDT VolitionRx Schedules First Quarter 2015 Earnings Conference Call and Business Update for Tuesday, May 12, 2015 at 8:30 a.m. ET
Apr 21, 2015 8:00 am EDT VolitionRx Initiates Study with Hvidovre Hospital, Denmark, Specifically to Target NuQ(R) Biomarker Panel for Colorectal Polyps
